Section Arrow
PASG.NASDAQ
- Passage Bio Inc
Quotes are at least 15-min delayed:2025/09/03 20:33 EDT
Regular Hours
Last
 7.125
+0.015 (+0.21%)
Day High 
7.5362 
Prev. Close
7.11 
1-M High
7.75 
Volume 
32.74K 
Bid
6.9
Ask
7.15
Day Low
6.65 
Open
6.87 
1-M Low
5.4092 
Market Cap 
22.60M 
Currency USD 
P/E 0.18 
%Yield -- 
10-SMA 7.22 
20-SMA 6.76 
50-SMA 6.82 
52-W High 26.6 
52-W Low 0.375 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
39.40/-10.91
Enterprise Value
44.39M
Balance Sheet
Book Value Per Share
12.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
STTKShattuck Labs1.28+0.27+26.73%-- 
Quotes are at least 15-min delayed:2025/09/03 20:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.